Posts from Group: Leadership

Brooke Yakatan

June 7th, 2017
Mr. Brooke Yakatan joined IRISYS in 2014. His responsibilities at IRISYS include the overseeing and maintaining of GMP compliance in both small- and large-scale manufacturing campaigns ranging from Phase 1 and Phase 2 to commercial products.

Kevin Xie

June 7th, 2017
Mr. Xie joined IRISYS in 2014 and is in charge of the Company’s finance, accounting and tax functions. He is responsible for financial planning and reporting, budgeting, cash management, payroll, internal control and tax filing and reporting.

Igor Nikoulin, Ph.D.

June 7th, 2017
Dr. Nikoulin established and directs the R&D and manufacturing capabilities for all dosage forms including nanoparticle-based drug delivery systems at IRISYS since joining the Company in 2013.

Victoria Smith Karpinski

June 7th, 2017
Ms. Karpinski joined IRISYS in 2014 and is responsible for managing people and activities that are at the hub of the organization.

Louis Scotti

June 7th, 2017
Mr. Scotti was appointed Vice President, Business Development at IRISYS in 2015 after previously serving on our Board of Directors from 2007 until 2012.

Robert Giannini, Ph.D.

June 7th, 2017
Dr. Giannini has more than 30 years of pharmaceutical industry experience. His breadth of knowledge includes development of a wide range of dosage forms such as controlled/extended release solids, oral liquids, and injectables.

Gerald J. Yakatan, Ph.D.

June 7th, 2017
Dr. Yakatan has served as Chairman & CEO of IRISYS since founding the Company in 1996. In addition to his leadership and oversight of IRISYS’ operations, Dr. Yakatan personally heads our Strategic Consulting services.

Jin Jean Wang, Ph.D.

June 2nd, 2017
Dr. Wang joined IRISYS in 2009. Her responsibilities include providing technical and quality guidance via directly overseeing quality control and regulatory filings.